BridgeMD
New treatment option for T2D
Official title Potatoes, Type 2 Diabetes, and Cardiometabolic Health
ClinicalTrials.gov ID: NCT07229482
What this study is testing
- What it's testing
- Type 2 diabetes (T2D) is a major chronic health condition which increases risk of coronary artery disease, frailty, cognitive decline, and mortality. Additionally, hypertension is a major comorbidity for individuals with T2D, further increasing the risk of adverse cardiovascular outcomes.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 70. Healthy volunteers may be eligible.
You may be able to join if
- Age 50-70 years
- Weight stable for previous 3 months (±5% body weight)
- Sedentary to recreationally active
- ADA-Risk Screener questionnaire score of at least 5
- No plans to gain or lose weight or change physical activity level
You likely can't join if
- Body mass index \>40 m2/kg
- Diabetes or diabetes medication
- Weight loss medication or medication influencing glucose metabolism
- Antibiotic, prebiotic or probiotic use in prior 3 months
- TCHOL \>6.2 mmol/L; TG \>4.5 mmol/L
- Blood pressure (BP) \> 159/99 mmHg or taking antihypertensive medication
See the full eligibility criteria
- Age 50-70 years
- Weight stable for previous 3 months (±5% body weight)
- Sedentary to recreationally active
- ADA-Risk Screener questionnaire score of at least 5
- No plans to gain or lose weight or change physical activity level
- Willing to pick up food daily and consume foods provided for a 14-week period
- Verbal and written informed consent
- Estrogen or testosterone use, lipid-lowering medication and thyroid replacement medication is acceptable, if on stable dose for \>6 months
- Body mass index \>40 m2/kg
- Diabetes or diabetes medication
- Weight loss medication or medication influencing glucose metabolism
- Antibiotic, prebiotic or probiotic use in prior 3 months
- TCHOL \>6.2 mmol/L; TG \>4.5 mmol/L
- Blood pressure (BP) \> 159/99 mmHg or taking antihypertensive medication
- Diagnosed inflammatory bowel disease
- Past or current heart diseases, stroke, respiratory disease, endocrine or metabolic disease, or hematological-oncological disease
- Vegetarian or vegan
- Pregnant or plans to become pregnant
- Food allergies or aversions to diet foods provided
- Estrogen or testosterone usage or lipid-lowering medication usage \<6 months
The study team makes the final eligibility decision.
Where it's taking place
- Blacksburg, Virginia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Blacksburg, Virginia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.